Can a smartphone app improve quality of life for blood cancer patients?

NCT ID NCT06472128

Recruiting now Symptom relief Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a digital app called DREAMLAND designed to improve quality of life and emotional well-being for adults with acute myeloid leukemia (AML) undergoing intensive chemotherapy. About 200 hospitalized patients will either use DREAMLAND or a standard wellness app. Researchers will compare how patients rate their quality of life at day 20 and beyond.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: digital application (DREAMLAND)
What this could lead to: If it works, this could provide a simple, self-guided digital tool to help AML patients feel better emotionally and physically during treatment.
What could go wrong: This is an early-stage behavioral study with 200 participants, so results may not apply to all patients. The app is only available in English, limiting who can use it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH RISK ACUTE MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIGH RISK ACUTE MYELOID LEUKEMIA PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA RELAPSED ADULT ACUTE MYELOID LEUKEMIA

Contacts and locations

Locations

Duke University
NOT_YET_RECRUITING

Durham, North Carolina, 27710, United States
Fred Hutchinson Cancer Research Center (FHCRC)
NOT_YET_RECRUITING

Seattle, Washington, 98109, United States
Massachusetts General Hospital (MGH)
RECRUITING

Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.